A new HORIBA Chair will work with industry and academia to champion and develop new propulsion technologies, creating the next generation of battery and fuel cell mobility and leading the way towards a cleaner, greener, and carbon-free future. University College London (UCL) researchers are closer to meeting the challenge of developing zero-emission transport, thanks to [...]

- David Bench resigning to pursue a new career opportunity - NEW YORK, NY -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the appointment of Patricia Eckert, CPA, as interim Chief Financial Officer (CFO). Ms. Eckert’s appointment follows the resignation of David Bench, who is [...]

TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, completed its planned milestones for the third quarter of 2022, further advancing its transcriptome-informed approach to drug design and discovery utilizing the company’s proprietary HTG EdgeSeq technology. Significant milestone progress made during [...]

Particle Works continues to pave the way for particle perfection with the highly anticipated launch of its second revolutionary platform, the Automated Library Synthesis (ALiS) System. This innovative platform enables automation and high-throughput screening of lipid nanoparticle (LNP) formulations and mRNA candidates in early-stage drug development. Liposomes and lipid nanoparticles are becoming increasingly important in [...]

Univercells, a global life science company providing all-round solutions for biologics manufacturing, has raised € 44 million through the first close of its Series D financing round. In addition to the support of existing private and public shareholders, Univercells is very pleased to welcome prominent new investors from Belgium and the United States. Brussels (Belgium) [...]

Maravai LifeSciences and Recently-Appointed CEO Trey Martin Vigorously Defending Against Suit SAN DIEGO, Calif. -- Executive Chairman and former CEO of Maravai LifeSciences, Inc. (NASDAQ: MRVI) Carl Hull, has been reinstated as CEO of the company on an interim basis. Three subsidiaries of Danaher Corporation, two of which previously employed recently-appointed Maravai CEO William “Trey” [...]

Initiative to focus on development, manufacture, and validation of publicly available somatic reference samples ARLINGTON, Va. -- The Medical Device Innovation Consortium (MDIC) has partnered with PerkinElmer's Horizon Discovery to develop and manufacture somatic reference samples (SRSs) to simplify and support validation of next generation sequencing (NGS)-based cancer diagnostics. The SRSs are expected to be commercially available [...]

Alliance panels include a 50-gene pharmacogenomics panel and a nearly 400-gene panel of challenging, medically relevant "dark genes" developed in collaboration with leading institutions MENLO PARK, Calif. and SOUTH SAN FRANCISCO -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality [...]

Agreement will allow researchers to streamline development of on-demand and automated production of CRISPR-Cas9 guide RNA SAN DIEGO -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, and Cellibre, a leading manufacturing technology company, today announced initiation of work under a collaboration to optimize the development and validation of Telesis [...]

PROVIDENCE RI -- Nabsys, the pioneer in electronic whole-genome mapping, announced that Justin Bingham has joined the company as its Chief Commercial Officer. “Justin brings highly relevant experience to Nabsys, both as a consumer of whole-genome technology and data and as a builder of commercial life sciences organizations,” said Barrett Bready, MD, Nabsys Founder and CEO. [...]